#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2156	608.5	0	.	n	.	0	C451T	SNP	451	451	C	739	739	T	702	T,C	489,175	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2156	608.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1472	1472	C	812	C,T,A	761,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23854	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	679.0	0	.	n	.	0	T695C	SNP	695	695	T	952	952	C	712	C,T	662,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23854	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	679.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1895	1895	G	775	G,A,C	405,333,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23854	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	679.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2228	2228	C	736	C	691	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23854	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	679.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2302	2302	A	757	A	718	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23854	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3498	679.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2854	2854	C	781	C	743	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1904	folP	855	855	100.0	folP.l15.c4.ctg.1	1489	127.0	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	174;171;169	A;G;C	164;162;160	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	153.2	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	170;168;169	T;T;C	165;162;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	153.2	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	168;169;164	G;G;C	160;160;157	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5172	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3362	153.2	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	168;169;164	G;G;C	160;160;157	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1520	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1265	119.2	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	192;191;194	G;G;C	179;178;178	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	792	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	869	90.0	0	.	n	.	0	A197.	DEL	197	197	A	508	508	A	196	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5418	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	182.1	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	223;222;223	G;A;C	200;196;200	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5418	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	182.1	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	224;221;221	C;G;T	202;198;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5418	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	182.1	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	224;221;221	C;G;T	202;198;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5418	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	182.1	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	224;221;221	C;G;T	202;198;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5418	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2960	182.1	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	221;222;221	T;C;C	198;202;198	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4242	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2653	159.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1532	1534	GGC	204;204;205	G;G;C	193;191;192	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1273	1275	GCC	162;162;163	G;C;C	153;154;154	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1276	1278	ATG	161;160;160	A;T;G	154;152;151	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1288	1290	ACC	162;164;161	A;C;C	146;150;147	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1288	1290	ACC	162;164;161	A;C;C	146;150;147	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1789	1791	ACC	208;212;214	A;C;C	186;196;199	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1843	1845	GCG	192;190;186	G;C;G	163;150;156	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1843	1845	GCG	192;190;186	G;C;G	163;150;156	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1966	1968	GGT	159;159;159	G,A;G;T,C	148,1;149;147,1	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1975	1977	GGC	158;157;158	G;G,T;C	144;143,1;143	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3606	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2336	153.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1993	1995	CCG	124;125;125	C,G;C;G	101,2;103;102	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5338	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3086	172.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1576	1578	CCG	193;193;192	C;C,A;G	172;177,1;176	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2276	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1736	130.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	159	C	150	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2638	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1565	167.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	424	426	GTT	201;201;202	G;T;T	196;192;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2638	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1565	167.8	0	.	p	.	0	G48A	NONSYN	142	144	GGA	433	435	GCA	193;195;198	G;C;A	182;183;186	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2638	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1565	167.8	1	SNP	p	G120K	1	.	.	358	360	AAG	649	651	AAG	226;225;225	A;A;G	211;213;210	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2638	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1565	167.8	1	SNP	p	A121N	1	.	.	361	363	AAC	652	654	AAC	226;225;224	A;A;C	212;210;209	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2638	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1565	167.8	1	SNP	p	N121D	0	.	.	361	363	AAC	652	654	AAC	226;225;224	A;A;C	212;210;209	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9298	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	5037	184.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1000	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1160	85.7	1	SNP	p	V57M	1	.	.	169	171	ATG	597	599	ATG	220;218;213	A,G;T;G	204,1;204;199	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
